Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Estrogen: a potential agent for prevention of dementia?

March 19, 1998

Cambridge NeuroScience remains optimistic about the potential of Cerestat

March 18, 1998

Lilly develops selective serotonergic agents

March 18, 1998

Efficacy and safety of long-term donepezil in patients with mild to moderate AD

March 18, 1998

Ebselen: neuroprotective agent in patients with neurological deficits after aneurysmal hemorrhage

March 18, 1998

Spherons: a time bomb in the human brain?

March 17, 1998

Neuroprotective glutamate antagonists from Warner-Lambert

March 17, 1998

Aricept launched in France

March 17, 1998

Depsipeptides useful in dementia under evaluation at Nisshin Flour Milling

March 17, 1998

Improved agents for schizophrenia developed at Yoshitomi

March 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...